Vyome Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 11.33%
- Profit Growth 39.09%
- Ebitda -178.36%
- Net Worth -1.13%
- Total Assets -0.32%
About Vyome Therapeutics
Vyome Therapeutics Limited (VTL) is a Public Limited Indian Non-Government Company incorporated in India on 30 August 2017 (Seven years and five months 2 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sivaram Swaminathan, Raghunath Mashelkar, Shiladitya Sengupta, and Two other members serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100GJ2017PLC098900
- Company No.
098900
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Vyome Therapeutics?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivaram Swaminathan  | Director | 09-Feb-2019 | Current |
| Raghunath Mashelkar | Director | 09-Feb-2019 | Current |
| Shiladitya Sengupta | Director | 30-Aug-2017 | Current |
| Ranjana Kumar | Director | 09-Feb-2019 | Current |
| Venkateswarlu Nelabhotla | Director | 30-Aug-2017 | Current |
Financial Performance of Vyome Therapeutics.
Vyome Therapeutics Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.33% increase. The company also saw a substantial improvement in profitability, with a 39.09% increase in profit. The company's net worth dipped by a decrease of 1.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vyome Therapeutics?
In 2022, Vyome Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vyome Biosciences Private LimitedShiladitya Sengupta, Ranjana Kumar and 1 more are mutual person
Medzara Healthtech Private LimitedVenkateswarlu Nelabhotla is a mutual person
International Longevity Centre- IndiaRaghunath Mashelkar is a mutual person
Aic Iiser Pune Seed FoundationSivaram Swaminathan is a mutual person
Sakal Media Private LimitedRaghunath Mashelkar is a mutual person
Invictus Oncology Private LimitedRaghunath Mashelkar and Shiladitya Sengupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vyome Therapeutics?
Vyome Therapeutics has a workforce of 6 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vyome Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vyome Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
